0.27
0.0049 (1.85%)
0.0049 (1.85%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biocept Inc | BIOC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.0155 | -5.52% | 0.2651 | 0.265 | 0.281 | 0.28 | 0.2806 | 16:17:19 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.2656 | 0.27 | 0.0044 | 1.63% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,458 | 4,010,453 | $ 0.2711179 | $ 1,087,306 | 20,253,126 | 0.2112 - 2.11 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:17:46 | 3 | $ 0.27 | USD |
Biocept Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 24.85M | 92.67M | $ -24.57M | -9.19 | - | 92.12M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Biocept News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIOC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3124 | 0.41 | 0.265 | 0.328774 | 12,671,875 | -0.0473 | -15.14% |
| 1 Month | 0.4599 | 0.69 | 0.2112 | 0.4202202 | 20,830,607 | -0.1948 | -42.36% |
| 3 Months | 0.3375 | 1.24 | 0.2112 | 0.4255571 | 14,142,334 | -0.0724 | -21.45% |
| 6 Months | 0.8134 | 1.24 | 0.2112 | 0.4097839 | 7,845,189 | -0.5483 | -67.41% |
| 1 Year | 1.16 | 2.11 | 0.2112 | 0.5974093 | 5,055,445 | -0.8949 | -77.15% |
| 3 Years | 2.11 | 12.15 | 0.141 | 0.826588 | 2,545,142 | -1.84 | -87.44% |
| 5 Years | 2.30 | 12.15 | 0.141 | 1.08 | 1,873,932 | -2.03 | -88.47% |
Biocept Description
| Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample. The company's lung, breast, and gastric cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. Its products include CEE-Sure BCT, and Target Selector Kits. Geographically, it operates through the United States, which is also the revenue generation region for the group. |
